These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30623240)

  • 1. Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis.
    Sauzullo I; Mengoni F; Mascia C; Pavone P; Savelloni G; Massetti AP; Lichtner M; Vullo V; Mastroianni CM
    Med Microbiol Immunol; 2019 Apr; 208(2):171-183. PubMed ID: 30623240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
    Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
    Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
    Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
    Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
    J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children.
    Buonsenso D; Delogu G; Perricone C; Grossi R; Careddu A; De Maio F; Palucci I; Sanguinetti M; Valentini P; Sali M
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J; Tesfaye F; Jansson M; Tolera Balcha T; Winqvist N; Kefeni M; Garoma Abeya S; Belachew F; Sturegård E; Björkman P
    PLoS One; 2018; 13(4):e0193589. PubMed ID: 29617458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
    Suzukawa M; Takeda K; Akashi S; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
    J Infect; 2020 May; 80(5):547-553. PubMed ID: 32092390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.
    Sotgiu G; Saderi L; Petruccioli E; Aliberti S; Piana A; Petrone L; Goletti D
    J Infect; 2019 Nov; 79(5):444-453. PubMed ID: 31473271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.